Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,615 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of hyperlipidemia from Japanese evidence.
Koba S, Sasaki J. Koba S, et al. Among authors: sasaki j. J Atheroscler Thromb. 2006 Dec;13(6):267-80. doi: 10.5551/jat.13.267. J Atheroscler Thromb. 2006. PMID: 17192691 Free article. Review.
Japanese dietary lifestyle and cardiovascular disease.
Tada N, Maruyama C, Koba S, Tanaka H, Birou S, Teramoto T, Sasaki J. Tada N, et al. Among authors: sasaki j. J Atheroscler Thromb. 2011;18(9):723-34. doi: 10.5551/jat.8193. Epub 2011 Jun 17. J Atheroscler Thromb. 2011. PMID: 21685707 Free article. Review.
Risk of coronary events in Japanese patients with both hypercholesterolemia and type 2 diabetes mellitus on low-dose simvastatin therapy: implication from Japan Lipid Intervention Trial (J-LIT).
Oikawa S, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group. Oikawa S, et al. Among authors: sasaki j. Atherosclerosis. 2007 Apr;191(2):440-6. doi: 10.1016/j.atherosclerosis.2006.04.017. Epub 2006 Jun 12. Atherosclerosis. 2007. PMID: 16765358
Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese adults.
Hata Y, Mabuchi H, Saito Y, Itakura H, Egusa G, Ito H, Teramoto T, Tsushima M, Tada N, Oikawa S, Yamada N, Yamashita S, Sakuma N, Sasaki J; Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias. Hata Y, et al. Among authors: sasaki j. J Atheroscler Thromb. 2002;9(1):1-27. doi: 10.5551/jat.9.1. J Atheroscler Thromb. 2002. PMID: 12238634 Free article.
Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS).
Oikawa S, Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K; JELIS Investigators, Japan. Oikawa S, et al. Among authors: sasaki j. Atherosclerosis. 2009 Oct;206(2):535-9. doi: 10.1016/j.atherosclerosis.2009.03.029. Epub 2009 Apr 5. Atherosclerosis. 2009. PMID: 19447387 Clinical Trial.
Clinical effects of rosuvastatin, a new HMG-CoA reductase inhibitor, in Japanese patients with primary hypercholesterolemia: an early phase II study.
Yamamoto A, Arakawa K, Sasaki J, Matsuzawa Y, Takemura K, Tsushima M, Fujinami T, Mabuchi H, Itakura H, Yamada N, Toyota T, Oikawa S; Rosuvastatin Dose-Ranging Trialist Group. Yamamoto A, et al. Among authors: sasaki j. J Atheroscler Thromb. 2002;9(1):48-56. doi: 10.5551/jat.9.48. J Atheroscler Thromb. 2002. PMID: 12238638 Free article. Clinical Trial.
Serum lipid survey and its recent trend in the general Japanese population in 2000.
Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H, Kita T. Arai H, et al. Among authors: sasaki j. J Atheroscler Thromb. 2005;12(2):98-106. doi: 10.5551/jat.12.98. J Atheroscler Thromb. 2005. PMID: 15942120 Free article.
1,615 results